// App-Quantinova.ai

4550 : Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts).

Researchers

Presenter

  • Samuel Funt

Principal Investigators

  • Deaglan Joseph McHugh

  • Stephanie Tsai

  • Devon O'Donnell

  • Andrea Knezevic

  • Sujata Patil

  • Deborah Silber

  • Victor E. Reuter

  • Joel Sheinfeld

  • Brett Stewart Carver

  • Maryann Carousso

  • Robert J. Motzer

  • Dean F. Bajorin

  • George J. Bosl

  • Darren R. Feldman

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved